Analyzing...
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2024 In continuation of our letter dated 18-Jul-24 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference call with Analysts / Investors on Financial Results of the Company for the quarter ended 30th June, 2024, has been placed on the Company’s website at https://www.torrentpharma.com/pdf/investors/Q1-FY24-25_Earnings-Call-Transcript.pdf Kindly take note of the above.
Thanking you,